Money Compass

Money Compass

Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA “Best Start-Up” Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)

SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All Epidermolysis Bullosa (EB) SubtypesThis second consecutive nomination places our company...

Read moreDetails
Page 32 of 3428 1 … 31 32 33 … 3,428

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.